Yanchuang Capital
Beijingyccapital.cn
Overview
Yanchuang Capital was founded in 2010 by the Office of Science and Technology of Peking University and PKU alumni. It focuses on equity investments, stock market securities investments, and M&A. In the healthcare sector, Yanchuang has invested in a number of biopharma / biotech companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Tennor Therapeutics | May 2026 | Series D | Lead |
| Volant Aerotech | Dec 2024 | VC Round | Co-investor |
| Avistone Pharmaceuticals | Jan 2024 | Series B | Co-investor |
| Lai Kai Pharmaceutical Technology | May 2022 | Series D | Co-investor |
| Laekna, Inc. | May 2022 | Series D | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
